Last €23.42 EUR
Change Today -0.208 / -0.88%
Volume 188.8K
RHK On Other Exchanges
Symbol
Exchange
Xetra
OTC US
OTC US
Xetra
As of 3:35 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

rhoen-klinikum ag (RHK) Snapshot

Open
€23.58
Previous Close
€23.63
Day High
€23.90
Day Low
€23.38
52 Week High
11/11/14 - €24.77
52 Week Low
02/3/14 - €20.69
Market Cap
1.7B
Average Volume 10 Days
191.9K
EPS TTM
€9.29
Shares Outstanding
73.5M
EX-Date
06/13/14
P/E TM
2.5x
Dividend
€0.24
Dividend Yield
1.01%
Current Stock Chart for RHOEN-KLINIKUM AG (RHK)

Related News

No related news articles were found.

rhoen-klinikum ag (RHK) Related Businessweek News

No Related Businessweek News Found

rhoen-klinikum ag (RHK) Details

RHÖN-KLlNlKUM Aktiengesellschaft provides healthcare services in Germany. As of April 30, 2014, the company had 10 hospitals in 5 locations and a total of 5,300 beds. It also had hospitals in Cuxhaven and Waltershausen-Friedrichroda. The company is headquartered in Bad Neustadt a.d. Saale, Germany.

15,898 Employees
Last Reported Date: 11/7/14

rhoen-klinikum ag (RHK) Top Compensated Officers

Chairman of Management Board
Total Annual Compensation: €1.0M
Chief Financial Officer and Member of Managem...
Total Annual Compensation: €733.0K
Member of Management Board and Regional Direc...
Total Annual Compensation: €450.0K
Compensation as of Fiscal Year 2013.

rhoen-klinikum ag (RHK) Key Developments

Rhoen-Klinikum AG to Invest Total of EUR 4 Million in Treatment and Healthcare Activities in 2015

Rhoen-Klinikum AG announced that it will invest a total of EUR 4 million in treatment and healthcare activities in 2015. The operator will finance a total of 61 projects at its five sites. The focus will be on personalised medical care that will involve the use of molecular genetics, as well as telemedical healthcare and e-health.

Rhön-Klinikum Aktiengesellschaft Presents at UniCredit und Kepler Cheuvreux 14th German Corporate Conference, Jan-19-2015

Rhön-Klinikum Aktiengesellschaft Presents at UniCredit und Kepler Cheuvreux 14th German Corporate Conference, Jan-19-2015 . Venue: Villa Kennedy, Kennedyallee 70, D-60596 Frankfurt, Germany.

Rhoen Klinikum AG Reports Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Rhoen Klinikum AG reported consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported income attributable to the shareholders of EUR 12.31 million, or EUR 0.09 per share, compared to EUR 17.09 million, or EUR 0.12 per share, for the same quarter ended September 30, 2013. Revenues were EUR 278.31 million, compared to EUR 749.57 million for the same quarter ended September 30, 2013. For the nine months, the company reported income attributable to the shareholders of EUR 1.22 billion, or EUR 8.86 per share, compared to EUR 65.94 million, or EUR 0.48 per share, for the same period ended September 30, 2013. Revenues were EUR 1.24 billion, compared to EUR 2.26 billion for the same period ended September 30, 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RHK:GR €23.42 EUR -0.208

RHK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Curanum AG €3.11 EUR -0.05
Korian-Medica €33.49 EUR -0.13
Maternus-Kliniken AG €0.36 EUR +0.007
Orpea €57.69 EUR -0.64
View Industry Companies
 

Industry Analysis

RHK

Industry Average

Valuation RHK Industry Range
Price/Earnings 2.3x
Price/Sales 1.3x
Price/Book 2.4x
Price/Cash Flow 1.2x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RHOEN-KLINIKUM AG, please visit www.rhoen-klinikum-ag.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.